4.
影响NSCLC患者预后的单因素分析
Univariate survival analysis of NSCLC patients
| Risk factors | n | Median survival time (months) | 95%CI | P |
| Gender | 0.364 5 | |||
| Male | 97 | 9 | 8.15-9.85 | |
| Female | 43 | 10 | 6.85-13.15 | |
| Age (year) | 0.497 4 | |||
| > 65 | 80 | 8 | 6.98-9.02 | |
| ≥65 | 60 | 10 | 8.3-11.7 | |
| Stage | 0.001 9 | |||
| Ⅲ | 77 | 11 | 9.35-12.65 | |
| Ⅳ | 63 | 8 | 7.22-8.78 | |
| PS scores | < 0.000 1 | |||
| 0-1 | 120 | 10 | 8.42-11.58 | |
| 2 | 20 | 6 | 4.55-7.45 | |
| Serum albumin (g/L) | 0.001 3 | |||
| ≤30 | 69 | 7 | 6.1-7.9 | |
| > 30 | 71 | 11 | 9.46-12.54 | |
| Cancer-related anemia | 0.000 1 | |||
| Yes | 110 | 8 | 7.27-8.73 | |
| No | 30 | 13 | 10.98-15.02 | |
| Chemotherapy regimen | 0.211 7 | |||
| Paclitaxel | 38 | 9 | 5.68-12.32 | |
| Non-paclitaxel | 102 | 9 | 8.11-9.89 |